1
Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin’s Lymphoma
Condition(s):Diffuse Large B-cell LymphomaLast Updated:March 30, 2023Recruiting
Lymphoma, B-Cell: 3173 Clinical Trials, Page 1 of 318
Hide Studies Not Open or Pending
2
Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma
Condition(s):Refractory or Relapsed B Cell LymphomaLast Updated:March 20, 2023Not yet recruiting
3
A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin’s Lymphoma
Condition(s):B-cell Non-Hodgkin’s LymphomaLast Updated:October 25, 2021Not yet recruiting
4
Multi-CAR-T Cells Targeting B Cell Lymphomas
Condition(s):B Cell Lymphoma (BCL)Last Updated:June 12, 2020Recruiting
5
Efficacy and Safety of Lenalidomide With or Without Rituximab and Other Drugs in B-cell Non-Hodgkin’s Lymphomas
Condition(s):Non-hodgkin Lymphoma,B CellLast Updated:July 7, 2020Unknown status
6
Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
Condition(s):B-Cell LymphomasLast Updated:November 23, 2011Completed
7
Rituximab and Pegylated Interferon α-2b in Patients With Indolent B-cell Lymphoma
Condition(s):Lymphoma, B-CellLast Updated:April 7, 2022Recruiting
8
Clinical Study of ET190L1 ARTEMIS™ in Relapsed, Refractory B Cell Lymphoma
Condition(s):Lymphoma, B-CellLast Updated:March 16, 2021Completed
9
Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma – BRA-DLBCL
Condition(s):Diffuse Large B Cell LymphomaLast Updated:September 21, 2023Recruiting
10
Prospective Clinical Study of ZPR Regimen in Elderly Treatment-naive Diffuse Large B-cell Lymphoma
Condition(s):Diffuse Large B Cell LymphomaLast Updated:July 11, 2023Recruiting